PHS
DGX icon

PFM Health Sciences’s Quest Diagnostics DGX Stock Holding History

PFM Health Sciences’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-88,933
Closed -$10.1M – 81
2020
Q2 		$10.1M Buy
+88,933
New +$9.43M 0.53% 60

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PFM Health Sciences's DGX Position: Q3 2020 in Review

PFM Health Sciences sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 88,933 shares — an estimated $10.1M sold.

PFM Health Sciences first reported a position in DGX in Q2 2020 and held it in 1 quarter. The position peaked at $10.1M in Q2 2020. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • PFM Health Sciences reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • PFM Health Sciences sold 88,933 Quest Diagnostics shares in Q3 2020, an estimated $10.1M.
  • PFM Health Sciences first reported a position in Quest Diagnostics in Q2 2020 and held it in 1 quarter.
  • PFM Health Sciences's Quest Diagnostics position peaked at $10.1M in Q2 2020.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on PFM Health Sciences's 13F filing for Q3 2020, filed 16 Nov 2020.